nodes	percent_of_prediction	percent_of_DWPC	metapath
Octreotide—MPO—Crohn's disease	0.42	1	CbGaD
Octreotide—MPO—Mesalazine—Crohn's disease	0.328	1	CbGbCtD
Octreotide—MPO—superior mesenteric artery—Crohn's disease	0.0287	0.58	CbGeAlD
Octreotide—SSTR4—mouth—Crohn's disease	0.00965	0.195	CbGeAlD
Octreotide—SSTR4—digestive system—Crohn's disease	0.00427	0.0862	CbGeAlD
Octreotide—SSTR2—digestive system—Crohn's disease	0.00234	0.0472	CbGeAlD
Octreotide—MPO—epithelium—Crohn's disease	0.00116	0.0235	CbGeAlD
Octreotide—MPO—skin of body—Crohn's disease	0.00111	0.0224	CbGeAlD
Octreotide—MPO—lymphoid tissue—Crohn's disease	0.000897	0.0181	CbGeAlD
Octreotide—MPO—digestive system—Crohn's disease	0.000886	0.0179	CbGeAlD
Octreotide—MPO—lymph node—Crohn's disease	0.000506	0.0102	CbGeAlD
Octreotide—Cystitis noninfective—Mesalazine—Crohn's disease	0.000402	0.00418	CcSEcCtD
Octreotide—Hepatobiliary disease—Mercaptopurine—Crohn's disease	0.000402	0.00417	CcSEcCtD
Octreotide—Influenza like illness—Mesalazine—Crohn's disease	0.0004	0.00416	CcSEcCtD
Octreotide—Cystitis—Mesalazine—Crohn's disease	0.000398	0.00413	CcSEcCtD
Octreotide—Candida infection—Mesalazine—Crohn's disease	0.000393	0.00409	CcSEcCtD
Octreotide—Vaginal infection—Mesalazine—Crohn's disease	0.000389	0.00404	CcSEcCtD
Octreotide—Neuropathy—Mesalazine—Crohn's disease	0.000387	0.00402	CcSEcCtD
Octreotide—Cramps of lower extremities—Mesalazine—Crohn's disease	0.000379	0.00393	CcSEcCtD
Octreotide—Multiple fractures—Prednisone—Crohn's disease	0.000375	0.0039	CcSEcCtD
Octreotide—Fracture—Prednisone—Crohn's disease	0.000375	0.0039	CcSEcCtD
Octreotide—Mouth ulceration—Mesalazine—Crohn's disease	0.000373	0.00387	CcSEcCtD
Octreotide—Bladder pain—Mesalazine—Crohn's disease	0.000373	0.00387	CcSEcCtD
Octreotide—Immune system disorder—Mercaptopurine—Crohn's disease	0.000344	0.00358	CcSEcCtD
Octreotide—Blood alkaline phosphatase increased—Mesalazine—Crohn's disease	0.000344	0.00357	CcSEcCtD
Octreotide—Hypothyroidism—Prednisone—Crohn's disease	0.00034	0.00353	CcSEcCtD
Octreotide—Gastroenteritis—Mesalazine—Crohn's disease	0.000337	0.00351	CcSEcCtD
Octreotide—Alopecia—Mercaptopurine—Crohn's disease	0.000337	0.0035	CcSEcCtD
Octreotide—Deafness—Mesalazine—Crohn's disease	0.000334	0.00347	CcSEcCtD
Octreotide—Malnutrition—Mercaptopurine—Crohn's disease	0.000332	0.00345	CcSEcCtD
Octreotide—Peptic ulcer—Prednisone—Crohn's disease	0.000326	0.00339	CcSEcCtD
Octreotide—Arthritis—Mesalazine—Crohn's disease	0.000308	0.0032	CcSEcCtD
Octreotide—Anaemia—Mercaptopurine—Crohn's disease	0.000307	0.00319	CcSEcCtD
Octreotide—Osteoarthritis—Mesalazine—Crohn's disease	0.000299	0.00311	CcSEcCtD
Octreotide—Gastrointestinal haemorrhage—Mesalazine—Crohn's disease	0.000299	0.00311	CcSEcCtD
Octreotide—Neuritis—Prednisone—Crohn's disease	0.000292	0.00303	CcSEcCtD
Octreotide—Arthralgia—Mercaptopurine—Crohn's disease	0.000283	0.00294	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.000281	0.00292	CcSEcCtD
Octreotide—Pancreatitis—Azathioprine—Crohn's disease	0.000278	0.00289	CcSEcCtD
Octreotide—Dry skin—Mesalazine—Crohn's disease	0.000274	0.00285	CcSEcCtD
Octreotide—Abdominal pain upper—Mesalazine—Crohn's disease	0.000273	0.00284	CcSEcCtD
Octreotide—Abdominal discomfort—Azathioprine—Crohn's disease	0.000272	0.00283	CcSEcCtD
Octreotide—Oedema—Mercaptopurine—Crohn's disease	0.000271	0.00281	CcSEcCtD
Octreotide—Cramp muscle—Mesalazine—Crohn's disease	0.000269	0.0028	CcSEcCtD
Octreotide—Nasopharyngitis—Mesalazine—Crohn's disease	0.000267	0.00278	CcSEcCtD
Octreotide—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.000265	0.00276	CcSEcCtD
Octreotide—Petechiae—Prednisone—Crohn's disease	0.000265	0.00275	CcSEcCtD
Octreotide—Gastritis—Mesalazine—Crohn's disease	0.000265	0.00275	CcSEcCtD
Octreotide—Skin disorder—Mercaptopurine—Crohn's disease	0.000263	0.00273	CcSEcCtD
Octreotide—Endocrine disorder—Prednisone—Crohn's disease	0.000263	0.00273	CcSEcCtD
Octreotide—Abdominal distension—Mesalazine—Crohn's disease	0.00026	0.0027	CcSEcCtD
Octreotide—Acne—Prednisone—Crohn's disease	0.000259	0.00269	CcSEcCtD
Octreotide—Asthma—Mesalazine—Crohn's disease	0.000259	0.00269	CcSEcCtD
Octreotide—Influenza—Mesalazine—Crohn's disease	0.000259	0.00269	CcSEcCtD
Octreotide—Anorexia—Mercaptopurine—Crohn's disease	0.000258	0.00268	CcSEcCtD
Octreotide—Pneumonia—Azathioprine—Crohn's disease	0.000255	0.00264	CcSEcCtD
Octreotide—Bronchospasm—Mesalazine—Crohn's disease	0.000254	0.00264	CcSEcCtD
Octreotide—Pancreatitis—Mesalazine—Crohn's disease	0.000253	0.00263	CcSEcCtD
Octreotide—Contusion—Prednisone—Crohn's disease	0.00025	0.0026	CcSEcCtD
Octreotide—Bronchitis—Mesalazine—Crohn's disease	0.000249	0.00258	CcSEcCtD
Octreotide—Amenorrhoea—Prednisone—Crohn's disease	0.000248	0.00258	CcSEcCtD
Octreotide—Abdominal discomfort—Mesalazine—Crohn's disease	0.000248	0.00257	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.000247	0.00256	CcSEcCtD
Octreotide—Dysuria—Mesalazine—Crohn's disease	0.000242	0.00251	CcSEcCtD
Octreotide—Viral infection—Prednisone—Crohn's disease	0.000241	0.00251	CcSEcCtD
Octreotide—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.00024	0.0025	CcSEcCtD
Octreotide—Arthropathy—Prednisone—Crohn's disease	0.00024	0.00249	CcSEcCtD
Octreotide—Hepatobiliary disease—Azathioprine—Crohn's disease	0.000239	0.00249	CcSEcCtD
Octreotide—Pollakiuria—Mesalazine—Crohn's disease	0.000239	0.00248	CcSEcCtD
Octreotide—Decreased appetite—Mercaptopurine—Crohn's disease	0.000235	0.00245	CcSEcCtD
Octreotide—Weight increased—Mesalazine—Crohn's disease	0.000235	0.00244	CcSEcCtD
Octreotide—Weight decreased—Mesalazine—Crohn's disease	0.000234	0.00243	CcSEcCtD
Octreotide—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.000234	0.00243	CcSEcCtD
Octreotide—Pneumonia—Mesalazine—Crohn's disease	0.000232	0.00241	CcSEcCtD
Octreotide—Depression—Mesalazine—Crohn's disease	0.00023	0.00239	CcSEcCtD
Octreotide—Neuropathy peripheral—Mesalazine—Crohn's disease	0.000226	0.00235	CcSEcCtD
Octreotide—Jaundice—Mesalazine—Crohn's disease	0.000225	0.00233	CcSEcCtD
Octreotide—Conjunctivitis—Mesalazine—Crohn's disease	0.000224	0.00233	CcSEcCtD
Octreotide—Urinary tract infection—Mesalazine—Crohn's disease	0.000224	0.00233	CcSEcCtD
Octreotide—Haematuria—Mesalazine—Crohn's disease	0.00022	0.00228	CcSEcCtD
Octreotide—Hepatobiliary disease—Mesalazine—Crohn's disease	0.000218	0.00226	CcSEcCtD
Octreotide—Epistaxis—Mesalazine—Crohn's disease	0.000217	0.00226	CcSEcCtD
Octreotide—Sinusitis—Mesalazine—Crohn's disease	0.000216	0.00225	CcSEcCtD
Octreotide—Body temperature increased—Mercaptopurine—Crohn's disease	0.000214	0.00222	CcSEcCtD
Octreotide—Rhinitis—Mesalazine—Crohn's disease	0.000207	0.00216	CcSEcCtD
Octreotide—Hepatitis—Mesalazine—Crohn's disease	0.000207	0.00215	CcSEcCtD
Octreotide—Pharyngitis—Mesalazine—Crohn's disease	0.000205	0.00213	CcSEcCtD
Octreotide—Immune system disorder—Azathioprine—Crohn's disease	0.000205	0.00213	CcSEcCtD
Octreotide—Neuropathy—Prednisone—Crohn's disease	0.000205	0.00213	CcSEcCtD
Octreotide—Oedema peripheral—Mesalazine—Crohn's disease	0.000204	0.00212	CcSEcCtD
Octreotide—Arrhythmia—Azathioprine—Crohn's disease	0.000203	0.00211	CcSEcCtD
Octreotide—Alopecia—Azathioprine—Crohn's disease	0.000201	0.00209	CcSEcCtD
Octreotide—Hypersensitivity—Mercaptopurine—Crohn's disease	0.0002	0.00207	CcSEcCtD
Octreotide—Tinnitus—Mesalazine—Crohn's disease	0.000193	0.002	CcSEcCtD
Octreotide—Cardiac disorder—Mesalazine—Crohn's disease	0.000192	0.002	CcSEcCtD
Octreotide—Hyperkinesia—Prednisone—Crohn's disease	0.00019	0.00198	CcSEcCtD
Octreotide—SSTR1—GPCR ligand binding—PTGER4—Crohn's disease	0.000187	0.00176	CbGpPWpGaD
Octreotide—Immune system disorder—Mesalazine—Crohn's disease	0.000187	0.00194	CcSEcCtD
Octreotide—Diarrhoea—Mercaptopurine—Crohn's disease	0.000185	0.00193	CcSEcCtD
Octreotide—SSTR4—Peptide ligand-binding receptors—CXCL8—Crohn's disease	0.000185	0.00174	CbGpPWpGaD
Octreotide—MPO—Folate Metabolism—IFNG—Crohn's disease	0.000184	0.00173	CbGpPWpGaD
Octreotide—Ill-defined disorder—Azathioprine—Crohn's disease	0.000183	0.00191	CcSEcCtD
Octreotide—Alopecia—Mesalazine—Crohn's disease	0.000183	0.0019	CcSEcCtD
Octreotide—Thrombophlebitis—Prednisone—Crohn's disease	0.000183	0.0019	CcSEcCtD
Octreotide—Anaemia—Azathioprine—Crohn's disease	0.000183	0.0019	CcSEcCtD
Octreotide—Diabetes mellitus—Prednisone—Crohn's disease	0.000182	0.00189	CcSEcCtD
Octreotide—SSTR1—GPCR downstream signaling—CCR9—Crohn's disease	0.000181	0.00171	CbGpPWpGaD
Octreotide—Mental disorder—Mesalazine—Crohn's disease	0.000181	0.00188	CcSEcCtD
Octreotide—Erythema—Mesalazine—Crohn's disease	0.00018	0.00187	CcSEcCtD
Octreotide—Malaise—Azathioprine—Crohn's disease	0.000178	0.00185	CcSEcCtD
Octreotide—Flatulence—Mesalazine—Crohn's disease	0.000177	0.00184	CcSEcCtD
Octreotide—Tension—Mesalazine—Crohn's disease	0.000177	0.00184	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—TAGAP—Crohn's disease	0.000177	0.00166	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—GPR65—Crohn's disease	0.000176	0.00166	CbGpPWpGaD
Octreotide—Nervousness—Mesalazine—Crohn's disease	0.000175	0.00182	CcSEcCtD
Octreotide—Cardiac failure congestive—Prednisone—Crohn's disease	0.000174	0.00181	CcSEcCtD
Octreotide—Back pain—Mesalazine—Crohn's disease	0.000174	0.00181	CcSEcCtD
Octreotide—SSTR2—GPCR ligand binding—CCR6—Crohn's disease	0.000174	0.00164	CbGpPWpGaD
Octreotide—Muscle spasms—Mesalazine—Crohn's disease	0.000173	0.0018	CcSEcCtD
Octreotide—Vomiting—Mercaptopurine—Crohn's disease	0.000172	0.00179	CcSEcCtD
Octreotide—Injury—Prednisone—Crohn's disease	0.000172	0.00179	CcSEcCtD
Octreotide—SSTR3—Signaling by GPCR—CCR9—Crohn's disease	0.000172	0.00162	CbGpPWpGaD
Octreotide—Rash—Mercaptopurine—Crohn's disease	0.000171	0.00177	CcSEcCtD
Octreotide—Dermatitis—Mercaptopurine—Crohn's disease	0.000171	0.00177	CcSEcCtD
Octreotide—Vision blurred—Mesalazine—Crohn's disease	0.00017	0.00176	CcSEcCtD
Octreotide—Tremor—Mesalazine—Crohn's disease	0.000169	0.00175	CcSEcCtD
Octreotide—SSTR1—GPCR downstream signaling—GPR65—Crohn's disease	0.000169	0.00159	CbGpPWpGaD
Octreotide—Amnesia—Prednisone—Crohn's disease	0.000168	0.00175	CcSEcCtD
Octreotide—Arthralgia—Azathioprine—Crohn's disease	0.000168	0.00175	CcSEcCtD
Octreotide—Myalgia—Azathioprine—Crohn's disease	0.000168	0.00175	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.000167	0.00174	CcSEcCtD
Octreotide—Ill-defined disorder—Mesalazine—Crohn's disease	0.000167	0.00174	CcSEcCtD
Octreotide—Anaemia—Mesalazine—Crohn's disease	0.000166	0.00173	CcSEcCtD
Octreotide—Discomfort—Azathioprine—Crohn's disease	0.000166	0.00173	CcSEcCtD
Octreotide—SSTR5—GPCR ligand binding—PTGER4—Crohn's disease	0.000166	0.00156	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—CCR6—Crohn's disease	0.000165	0.00156	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—CCR9—Crohn's disease	0.000165	0.00155	CbGpPWpGaD
Octreotide—MPO—Folate Metabolism—IL1B—Crohn's disease	0.000164	0.00155	CbGpPWpGaD
Octreotide—Malaise—Mesalazine—Crohn's disease	0.000162	0.00169	CcSEcCtD
Octreotide—Vertigo—Mesalazine—Crohn's disease	0.000162	0.00168	CcSEcCtD
Octreotide—Syncope—Mesalazine—Crohn's disease	0.000162	0.00168	CcSEcCtD
Octreotide—Nausea—Mercaptopurine—Crohn's disease	0.000161	0.00167	CcSEcCtD
Octreotide—SSTR5—GPCR downstream signaling—CCR9—Crohn's disease	0.000161	0.00151	CbGpPWpGaD
Octreotide—Infection—Azathioprine—Crohn's disease	0.00016	0.00167	CcSEcCtD
Octreotide—MPO—Selenium Micronutrient Network—ALB—Crohn's disease	0.00016	0.00151	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—GPR65—Crohn's disease	0.00016	0.0015	CbGpPWpGaD
Octreotide—Palpitations—Mesalazine—Crohn's disease	0.000159	0.00165	CcSEcCtD
Octreotide—Loss of consciousness—Mesalazine—Crohn's disease	0.000158	0.00164	CcSEcCtD
Octreotide—Gastrointestinal haemorrhage—Prednisone—Crohn's disease	0.000158	0.00164	CcSEcCtD
Octreotide—Osteoarthritis—Prednisone—Crohn's disease	0.000158	0.00164	CcSEcCtD
Octreotide—Thrombocytopenia—Azathioprine—Crohn's disease	0.000158	0.00164	CcSEcCtD
Octreotide—Cough—Mesalazine—Crohn's disease	0.000157	0.00163	CcSEcCtD
Octreotide—SSTR1—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	0.000157	0.00148	CbGpPWpGaD
Octreotide—Skin disorder—Azathioprine—Crohn's disease	0.000157	0.00163	CcSEcCtD
Octreotide—SSTR4—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000156	0.00147	CbGpPWpGaD
Octreotide—Hypertension—Mesalazine—Crohn's disease	0.000156	0.00162	CcSEcCtD
Octreotide—Psychotic disorder—Prednisone—Crohn's disease	0.000155	0.00161	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—RSPO3—Crohn's disease	0.000154	0.00145	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—ACKR2—Crohn's disease	0.000154	0.00145	CbGpPWpGaD
Octreotide—Chest pain—Mesalazine—Crohn's disease	0.000153	0.00159	CcSEcCtD
Octreotide—Myalgia—Mesalazine—Crohn's disease	0.000153	0.00159	CcSEcCtD
Octreotide—Arthralgia—Mesalazine—Crohn's disease	0.000153	0.00159	CcSEcCtD
Octreotide—SSTR2—GPCR ligand binding—PTGER4—Crohn's disease	0.000153	0.00144	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—GPR65—Crohn's disease	0.000153	0.00144	CbGpPWpGaD
Octreotide—MPO—IL23-mediated signaling events—IL6—Crohn's disease	0.000153	0.00144	CbGpPWpGaD
Octreotide—Anxiety—Mesalazine—Crohn's disease	0.000153	0.00159	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.000152	0.00158	CcSEcCtD
Octreotide—Discomfort—Mesalazine—Crohn's disease	0.000152	0.00157	CcSEcCtD
Octreotide—Irritability—Prednisone—Crohn's disease	0.000151	0.00157	CcSEcCtD
Octreotide—SSTR1—SIDS Susceptibility Pathways—IL1B—Crohn's disease	0.000151	0.00142	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—CCR6—Crohn's disease	0.00015	0.00141	CbGpPWpGaD
Octreotide—Dry mouth—Mesalazine—Crohn's disease	0.00015	0.00156	CcSEcCtD
Octreotide—SSTR5—GPCR downstream signaling—GPR65—Crohn's disease	0.00015	0.00141	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—CCR9—Crohn's disease	0.000148	0.0014	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—ACKR2—Crohn's disease	0.000148	0.00139	CbGpPWpGaD
Octreotide—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000147	0.00153	CcSEcCtD
Octreotide—Anaphylactic shock—Mesalazine—Crohn's disease	0.000147	0.00153	CcSEcCtD
Octreotide—Oedema—Mesalazine—Crohn's disease	0.000147	0.00153	CcSEcCtD
Octreotide—MPO—C-MYB transcription factor network—CD4—Crohn's disease	0.000147	0.00138	CbGpPWpGaD
Octreotide—MPO—Vitamin B12 Metabolism—TNF—Crohn's disease	0.000147	0.00138	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—SEL1L—Crohn's disease	0.000146	0.00138	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MLN—Crohn's disease	0.000146	0.00138	CbGpPWpGaD
Octreotide—MPO—Selenium Micronutrient Network—IFNG—Crohn's disease	0.000146	0.00138	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—CCR9—Crohn's disease	0.000146	0.00137	CbGpPWpGaD
Octreotide—Infection—Mesalazine—Crohn's disease	0.000146	0.00152	CcSEcCtD
Octreotide—MPO—C-MYB transcription factor network—PTGS2—Crohn's disease	0.000146	0.00137	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—PTGER4—Crohn's disease	0.000146	0.00137	CbGpPWpGaD
Octreotide—Dry skin—Prednisone—Crohn's disease	0.000145	0.00151	CcSEcCtD
Octreotide—Shock—Mesalazine—Crohn's disease	0.000145	0.0015	CcSEcCtD
Octreotide—Nervous system disorder—Mesalazine—Crohn's disease	0.000144	0.0015	CcSEcCtD
Octreotide—Thrombocytopenia—Mesalazine—Crohn's disease	0.000144	0.0015	CcSEcCtD
Octreotide—Tachycardia—Mesalazine—Crohn's disease	0.000143	0.00149	CcSEcCtD
Octreotide—Skin disorder—Mesalazine—Crohn's disease	0.000143	0.00148	CcSEcCtD
Octreotide—Hyperhidrosis—Mesalazine—Crohn's disease	0.000142	0.00148	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—MLN—Crohn's disease	0.00014	0.00132	CbGpPWpGaD
Octreotide—MPO—Selenium Micronutrient Network—PTGS2—Crohn's disease	0.00014	0.00132	CbGpPWpGaD
Octreotide—Anorexia—Mesalazine—Crohn's disease	0.00014	0.00146	CcSEcCtD
Octreotide—SSTR3—Peptide ligand-binding receptors—CXCL8—Crohn's disease	0.00014	0.00132	CbGpPWpGaD
Octreotide—Muscular weakness—Prednisone—Crohn's disease	0.00014	0.00145	CcSEcCtD
Octreotide—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000139	0.00145	CcSEcCtD
Octreotide—SSTR2—GPCR downstream signaling—GPR65—Crohn's disease	0.000138	0.0013	CbGpPWpGaD
Octreotide—Abdominal distension—Prednisone—Crohn's disease	0.000138	0.00143	CcSEcCtD
Octreotide—SSTR5—Signaling by GPCR—GPR65—Crohn's disease	0.000136	0.00128	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—CCR9—Crohn's disease	0.000135	0.00127	CbGpPWpGaD
Octreotide—SSTR1—Peptide ligand-binding receptors—CXCL8—Crohn's disease	0.000134	0.00126	CbGpPWpGaD
Octreotide—Pancreatitis—Prednisone—Crohn's disease	0.000134	0.00139	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000134	0.00139	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—TAGAP—Crohn's disease	0.000134	0.00126	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CCR9—Crohn's disease	0.000134	0.00126	CbGpPWpGaD
Octreotide—Sweating increased—Prednisone—Crohn's disease	0.000133	0.00138	CcSEcCtD
Octreotide—Feeling abnormal—Azathioprine—Crohn's disease	0.000133	0.00138	CcSEcCtD
Octreotide—Insomnia—Mesalazine—Crohn's disease	0.000133	0.00138	CcSEcCtD
Octreotide—SSTR4—Signaling by GPCR—PTGER4—Crohn's disease	0.000132	0.00124	CbGpPWpGaD
Octreotide—Paraesthesia—Mesalazine—Crohn's disease	0.000132	0.00137	CcSEcCtD
Octreotide—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000132	0.00137	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—ACKR2—Crohn's disease	0.000131	0.00124	CbGpPWpGaD
Octreotide—Dyspnoea—Mesalazine—Crohn's disease	0.000131	0.00136	CcSEcCtD
Octreotide—Somnolence—Mesalazine—Crohn's disease	0.000131	0.00136	CcSEcCtD
Octreotide—MPO—Selenium Micronutrient Network—IL1B—Crohn's disease	0.000131	0.00123	CbGpPWpGaD
Octreotide—Dyspepsia—Mesalazine—Crohn's disease	0.000129	0.00134	CcSEcCtD
Octreotide—SSTR2—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	0.000129	0.00121	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—TAGAP—Crohn's disease	0.000128	0.00121	CbGpPWpGaD
Octreotide—Decreased appetite—Mesalazine—Crohn's disease	0.000128	0.00133	CcSEcCtD
Octreotide—Body temperature increased—Azathioprine—Crohn's disease	0.000128	0.00133	CcSEcCtD
Octreotide—Abdominal pain—Azathioprine—Crohn's disease	0.000128	0.00133	CcSEcCtD
Octreotide—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000127	0.00132	CcSEcCtD
Octreotide—Fatigue—Mesalazine—Crohn's disease	0.000127	0.00132	CcSEcCtD
Octreotide—Pain—Mesalazine—Crohn's disease	0.000126	0.00131	CcSEcCtD
Octreotide—Constipation—Mesalazine—Crohn's disease	0.000126	0.00131	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—GPR65—Crohn's disease	0.000125	0.00118	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—CCR6—Crohn's disease	0.000125	0.00118	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MLN—Crohn's disease	0.000124	0.00117	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—GPR65—Crohn's disease	0.000124	0.00117	CbGpPWpGaD
Octreotide—Weight increased—Prednisone—Crohn's disease	0.000124	0.00129	CcSEcCtD
Octreotide—SSTR4—GPCR downstream signaling—IL3—Crohn's disease	0.000124	0.00117	CbGpPWpGaD
Octreotide—SSTR4—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000124	0.00117	CbGpPWpGaD
Octreotide—Weight decreased—Prednisone—Crohn's disease	0.000124	0.00129	CcSEcCtD
Octreotide—Hyperglycaemia—Prednisone—Crohn's disease	0.000123	0.00128	CcSEcCtD
Octreotide—SSTR2—SIDS Susceptibility Pathways—IL1B—Crohn's disease	0.000123	0.00116	CbGpPWpGaD
Octreotide—Depression—Prednisone—Crohn's disease	0.000122	0.00126	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—ACKR2—Crohn's disease	0.000121	0.00114	CbGpPWpGaD
Octreotide—Feeling abnormal—Mesalazine—Crohn's disease	0.000121	0.00126	CcSEcCtD
Octreotide—Gastrointestinal pain—Mesalazine—Crohn's disease	0.00012	0.00125	CcSEcCtD
Octreotide—SSTR1—GPCR downstream signaling—CCR6—Crohn's disease	0.00012	0.00113	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—RASGRP1—Crohn's disease	0.00012	0.00113	CbGpPWpGaD
Octreotide—Neuropathy peripheral—Prednisone—Crohn's disease	0.00012	0.00124	CcSEcCtD
Octreotide—MPO—Folate Metabolism—TNF—Crohn's disease	0.000119	0.00112	CbGpPWpGaD
Octreotide—SSTR5—Peptide ligand-binding receptors—CXCL8—Crohn's disease	0.000119	0.00112	CbGpPWpGaD
Octreotide—Hypersensitivity—Azathioprine—Crohn's disease	0.000119	0.00124	CcSEcCtD
Octreotide—MPO—Vitamin B12 Metabolism—IL6—Crohn's disease	0.000118	0.00111	CbGpPWpGaD
Octreotide—SSTR3—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000118	0.00111	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—RSPO3—Crohn's disease	0.000117	0.0011	CbGpPWpGaD
Octreotide—Urticaria—Mesalazine—Crohn's disease	0.000117	0.00121	CcSEcCtD
Octreotide—Abdominal pain—Mesalazine—Crohn's disease	0.000116	0.00121	CcSEcCtD
Octreotide—Body temperature increased—Mesalazine—Crohn's disease	0.000116	0.00121	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—MLN—Crohn's disease	0.000115	0.00108	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TAGAP—Crohn's disease	0.000114	0.00107	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—CCR6—Crohn's disease	0.000114	0.00107	CbGpPWpGaD
Octreotide—SSTR1—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000113	0.00106	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—IL3—Crohn's disease	0.000113	0.00106	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—RSPO3—Crohn's disease	0.000112	0.00106	CbGpPWpGaD
Octreotide—Bradycardia—Prednisone—Crohn's disease	0.000111	0.00116	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—SEL1L—Crohn's disease	0.000111	0.00104	CbGpPWpGaD
Octreotide—Diarrhoea—Azathioprine—Crohn's disease	0.00011	0.00115	CcSEcCtD
Octreotide—SSTR3—GPCR downstream signaling—PTGER4—Crohn's disease	0.00011	0.00104	CbGpPWpGaD
Octreotide—SSTR2—Peptide ligand-binding receptors—CXCL8—Crohn's disease	0.00011	0.00103	CbGpPWpGaD
Octreotide—SSTR1—SIDS Susceptibility Pathways—TNF—Crohn's disease	0.000109	0.00103	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—CCR6—Crohn's disease	0.000109	0.00103	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—RASGRP1—Crohn's disease	0.000109	0.00102	CbGpPWpGaD
Octreotide—Hypersensitivity—Mesalazine—Crohn's disease	0.000108	0.00113	CcSEcCtD
Octreotide—Dizziness—Azathioprine—Crohn's disease	0.000107	0.00111	CcSEcCtD
Octreotide—SSTR5—GPCR downstream signaling—CCR6—Crohn's disease	0.000107	0.001	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—SEL1L—Crohn's disease	0.000106	0.001	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—PTGER4—Crohn's disease	0.000106	0.000995	CbGpPWpGaD
Octreotide—Asthenia—Mesalazine—Crohn's disease	0.000105	0.0011	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—TAGAP—Crohn's disease	0.000105	0.000989	CbGpPWpGaD
Octreotide—Pruritus—Mesalazine—Crohn's disease	0.000104	0.00108	CcSEcCtD
Octreotide—Vomiting—Azathioprine—Crohn's disease	0.000103	0.00107	CcSEcCtD
Octreotide—Rash—Azathioprine—Crohn's disease	0.000102	0.00106	CcSEcCtD
Octreotide—Dermatitis—Azathioprine—Crohn's disease	0.000102	0.00106	CcSEcCtD
Octreotide—Flushing—Prednisone—Crohn's disease	0.000102	0.00106	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—CCR9—Crohn's disease	0.000101	0.000955	CbGpPWpGaD
Octreotide—Headache—Azathioprine—Crohn's disease	0.000101	0.00105	CcSEcCtD
Octreotide—Diarrhoea—Mesalazine—Crohn's disease	0.000101	0.00104	CcSEcCtD
Octreotide—SSTR5—G alpha (i) signalling events—CXCL8—Crohn's disease	0.0001	0.000944	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—PTGER4—Crohn's disease	0.0001	0.000943	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—RSPO3—Crohn's disease	9.95e-05	0.000937	CbGpPWpGaD
Octreotide—Immune system disorder—Prednisone—Crohn's disease	9.89e-05	0.00103	CcSEcCtD
Octreotide—SSTR2—GPCR downstream signaling—CCR6—Crohn's disease	9.83e-05	0.000925	CbGpPWpGaD
Octreotide—Arrhythmia—Prednisone—Crohn's disease	9.78e-05	0.00102	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—CCR9—Crohn's disease	9.73e-05	0.000916	CbGpPWpGaD
Octreotide—Dizziness—Mesalazine—Crohn's disease	9.72e-05	0.00101	CcSEcCtD
Octreotide—SSTR5—Signaling by GPCR—CCR6—Crohn's disease	9.68e-05	0.000911	CbGpPWpGaD
Octreotide—Alopecia—Prednisone—Crohn's disease	9.67e-05	0.00101	CcSEcCtD
Octreotide—MPO—Folate Metabolism—IL6—Crohn's disease	9.62e-05	0.000905	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—PTGER4—Crohn's disease	9.61e-05	0.000904	CbGpPWpGaD
Octreotide—Mental disorder—Prednisone—Crohn's disease	9.59e-05	0.000996	CcSEcCtD
Octreotide—Nausea—Azathioprine—Crohn's disease	9.59e-05	0.000996	CcSEcCtD
Octreotide—Malnutrition—Prednisone—Crohn's disease	9.53e-05	0.00099	CcSEcCtD
Octreotide—Erythema—Prednisone—Crohn's disease	9.53e-05	0.00099	CcSEcCtD
Octreotide—MPO—Selenium Micronutrient Network—TNF—Crohn's disease	9.47e-05	0.000891	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—SEL1L—Crohn's disease	9.44e-05	0.000888	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—GPR65—Crohn's disease	9.44e-05	0.000888	CbGpPWpGaD
Octreotide—SSTR4—GPCR ligand binding—CXCL8—Crohn's disease	9.43e-05	0.000887	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—IL3—Crohn's disease	9.4e-05	0.000884	CbGpPWpGaD
Octreotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	9.38e-05	0.000883	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—PTGER4—Crohn's disease	9.38e-05	0.000883	CbGpPWpGaD
Octreotide—Vomiting—Mesalazine—Crohn's disease	9.35e-05	0.000971	CcSEcCtD
Octreotide—Rash—Mesalazine—Crohn's disease	9.27e-05	0.000963	CcSEcCtD
Octreotide—SSTR2—G alpha (i) signalling events—CXCL8—Crohn's disease	9.26e-05	0.000872	CbGpPWpGaD
Octreotide—Dermatitis—Mesalazine—Crohn's disease	9.26e-05	0.000962	CcSEcCtD
Octreotide—Headache—Mesalazine—Crohn's disease	9.21e-05	0.000957	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—RSPO3—Crohn's disease	9.19e-05	0.000864	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—RASGRP1—Crohn's disease	9.09e-05	0.000855	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—GPR65—Crohn's disease	9.05e-05	0.000851	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—IL3—Crohn's disease	9.01e-05	0.000848	CbGpPWpGaD
Octreotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	9e-05	0.000847	CbGpPWpGaD
Octreotide—Vision blurred—Prednisone—Crohn's disease	8.98e-05	0.000933	CcSEcCtD
Octreotide—SSTR2—SIDS Susceptibility Pathways—TNF—Crohn's disease	8.95e-05	0.000842	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—CCR6—Crohn's disease	8.93e-05	0.00084	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CCR6—Crohn's disease	8.87e-05	0.000835	CbGpPWpGaD
Octreotide—Ill-defined disorder—Prednisone—Crohn's disease	8.84e-05	0.000919	CcSEcCtD
Octreotide—SSTR1—SIDS Susceptibility Pathways—IL6—Crohn's disease	8.82e-05	0.00083	CbGpPWpGaD
Octreotide—Anaemia—Prednisone—Crohn's disease	8.81e-05	0.000915	CcSEcCtD
Octreotide—Agitation—Prednisone—Crohn's disease	8.76e-05	0.00091	CcSEcCtD
Octreotide—Nausea—Mesalazine—Crohn's disease	8.73e-05	0.000907	CcSEcCtD
Octreotide—SSTR1—GPCR downstream signaling—RASGRP1—Crohn's disease	8.71e-05	0.00082	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—SEL1L—Crohn's disease	8.71e-05	0.000819	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—IL2RA—Crohn's disease	8.69e-05	0.000817	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—PTGER4—Crohn's disease	8.66e-05	0.000815	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CCR9—Crohn's disease	8.63e-05	0.000812	CbGpPWpGaD
Octreotide—Malaise—Prednisone—Crohn's disease	8.59e-05	0.000893	CcSEcCtD
Octreotide—Vertigo—Prednisone—Crohn's disease	8.56e-05	0.00089	CcSEcCtD
Octreotide—Syncope—Prednisone—Crohn's disease	8.55e-05	0.000888	CcSEcCtD
Octreotide—SSTR3—Signaling by GPCR—IL3—Crohn's disease	8.53e-05	0.000803	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—PTGER4—Crohn's disease	8.52e-05	0.000802	CbGpPWpGaD
Octreotide—Loss of consciousness—Prednisone—Crohn's disease	8.38e-05	0.00087	CcSEcCtD
Octreotide—Convulsion—Prednisone—Crohn's disease	8.26e-05	0.000858	CcSEcCtD
Octreotide—SSTR3—Signaling by GPCR—RASGRP1—Crohn's disease	8.25e-05	0.000777	CbGpPWpGaD
Octreotide—Hypertension—Prednisone—Crohn's disease	8.23e-05	0.000855	CcSEcCtD
Octreotide—SSTR1—Signaling by GPCR—IL3—Crohn's disease	8.18e-05	0.00077	CbGpPWpGaD
Octreotide—Myalgia—Prednisone—Crohn's disease	8.11e-05	0.000843	CcSEcCtD
Octreotide—Arthralgia—Prednisone—Crohn's disease	8.11e-05	0.000843	CcSEcCtD
Octreotide—Anxiety—Prednisone—Crohn's disease	8.09e-05	0.00084	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	8.06e-05	0.000837	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—GPR65—Crohn's disease	8.02e-05	0.000755	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—RBX1—Crohn's disease	8.02e-05	0.000755	CbGpPWpGaD
Octreotide—Discomfort—Prednisone—Crohn's disease	8.02e-05	0.000833	CcSEcCtD
Octreotide—SSTR5—GPCR downstream signaling—IL3—Crohn's disease	7.99e-05	0.000752	CbGpPWpGaD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	7.98e-05	0.000751	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CCR9—Crohn's disease	7.96e-05	0.000749	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—RASGRP1—Crohn's disease	7.91e-05	0.000745	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—IL2RA—Crohn's disease	7.89e-05	0.000742	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—PTGER4—Crohn's disease	7.86e-05	0.00074	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PTGER4—Crohn's disease	7.81e-05	0.000735	CbGpPWpGaD
Octreotide—Oedema—Prednisone—Crohn's disease	7.78e-05	0.000808	CcSEcCtD
Octreotide—Anaphylactic shock—Prednisone—Crohn's disease	7.78e-05	0.000808	CcSEcCtD
Octreotide—SSTR5—GPCR downstream signaling—RASGRP1—Crohn's disease	7.73e-05	0.000727	CbGpPWpGaD
Octreotide—Infection—Prednisone—Crohn's disease	7.73e-05	0.000803	CcSEcCtD
Octreotide—Shock—Prednisone—Crohn's disease	7.65e-05	0.000795	CcSEcCtD
Octreotide—MPO—Selenium Micronutrient Network—IL6—Crohn's disease	7.64e-05	0.000719	CbGpPWpGaD
Octreotide—Nervous system disorder—Prednisone—Crohn's disease	7.63e-05	0.000792	CcSEcCtD
Octreotide—Tachycardia—Prednisone—Crohn's disease	7.59e-05	0.000789	CcSEcCtD
Octreotide—Skin disorder—Prednisone—Crohn's disease	7.55e-05	0.000785	CcSEcCtD
Octreotide—Hyperhidrosis—Prednisone—Crohn's disease	7.52e-05	0.000781	CcSEcCtD
Octreotide—Anorexia—Prednisone—Crohn's disease	7.41e-05	0.00077	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—GPR65—Crohn's disease	7.4e-05	0.000697	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—IL3—Crohn's disease	7.37e-05	0.000694	CbGpPWpGaD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	7.36e-05	0.000693	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—IL3—Crohn's disease	7.26e-05	0.000683	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—IL6—Crohn's disease	7.22e-05	0.000679	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—CXCL8—Crohn's disease	7.15e-05	0.000672	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—RASGRP1—Crohn's disease	7.13e-05	0.000671	CbGpPWpGaD
Octreotide—Musculoskeletal discomfort—Prednisone—Crohn's disease	7.09e-05	0.000736	CcSEcCtD
Octreotide—Insomnia—Prednisone—Crohn's disease	7.03e-05	0.000731	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—UBE2D1—Crohn's disease	7.03e-05	0.000662	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—RASGRP1—Crohn's disease	7.02e-05	0.00066	CbGpPWpGaD
Octreotide—Paraesthesia—Prednisone—Crohn's disease	6.98e-05	0.000726	CcSEcCtD
Octreotide—SSTR1—GPCR ligand binding—CXCL8—Crohn's disease	6.85e-05	0.000645	CbGpPWpGaD
Octreotide—Dyspepsia—Prednisone—Crohn's disease	6.85e-05	0.000711	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—RIPK2—Crohn's disease	6.82e-05	0.000642	CbGpPWpGaD
Octreotide—Decreased appetite—Prednisone—Crohn's disease	6.76e-05	0.000702	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—CCR6—Crohn's disease	6.72e-05	0.000633	CbGpPWpGaD
Octreotide—Fatigue—Prednisone—Crohn's disease	6.71e-05	0.000697	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—IL3—Crohn's disease	6.7e-05	0.00063	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—IL3—Crohn's disease	6.65e-05	0.000626	CbGpPWpGaD
Octreotide—Constipation—Prednisone—Crohn's disease	6.65e-05	0.000691	CcSEcCtD
Octreotide—SSTR3—GPCR downstream signaling—IL2RA—Crohn's disease	6.58e-05	0.00062	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—RASGRP1—Crohn's disease	6.48e-05	0.00061	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CCR6—Crohn's disease	6.45e-05	0.000607	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—RASGRP1—Crohn's disease	6.43e-05	0.000605	CbGpPWpGaD
Octreotide—Feeling abnormal—Prednisone—Crohn's disease	6.41e-05	0.000666	CcSEcCtD
Octreotide—Gastrointestinal pain—Prednisone—Crohn's disease	6.36e-05	0.000661	CcSEcCtD
Octreotide—SSTR1—GPCR downstream signaling—IL2RA—Crohn's disease	6.31e-05	0.000594	CbGpPWpGaD
Octreotide—Urticaria—Prednisone—Crohn's disease	6.18e-05	0.000642	CcSEcCtD
Octreotide—Abdominal pain—Prednisone—Crohn's disease	6.15e-05	0.000639	CcSEcCtD
Octreotide—Body temperature increased—Prednisone—Crohn's disease	6.15e-05	0.000639	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—RBX1—Crohn's disease	6.08e-05	0.000572	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—CXCL8—Crohn's disease	6.08e-05	0.000572	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—IL2RA—Crohn's disease	5.98e-05	0.000563	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PTGER4—Crohn's disease	5.92e-05	0.000557	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—JAK2—Crohn's disease	5.84e-05	0.000549	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—SOCS1—Crohn's disease	5.83e-05	0.000549	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—RBX1—Crohn's disease	5.83e-05	0.000549	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—IL2RA—Crohn's disease	5.73e-05	0.000539	CbGpPWpGaD
Octreotide—Hypersensitivity—Prednisone—Crohn's disease	5.73e-05	0.000595	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—CCR6—Crohn's disease	5.72e-05	0.000538	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PTGER4—Crohn's disease	5.67e-05	0.000534	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—CXCL8—Crohn's disease	5.61e-05	0.000528	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—IL2RA—Crohn's disease	5.6e-05	0.000527	CbGpPWpGaD
Octreotide—Asthenia—Prednisone—Crohn's disease	5.58e-05	0.00058	CcSEcCtD
Octreotide—SSTR4—Signaling by GPCR—TYK2—Crohn's disease	5.56e-05	0.000523	CbGpPWpGaD
Octreotide—Pruritus—Prednisone—Crohn's disease	5.5e-05	0.000572	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—UBE2D1—Crohn's disease	5.33e-05	0.000502	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—CXCL8—Crohn's disease	5.33e-05	0.000501	CbGpPWpGaD
Octreotide—Diarrhoea—Prednisone—Crohn's disease	5.32e-05	0.000553	CcSEcCtD
Octreotide—SSTR4—Signaling by GPCR—JAK2—Crohn's disease	5.3e-05	0.000499	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CCR6—Crohn's disease	5.28e-05	0.000496	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—RBX1—Crohn's disease	5.17e-05	0.000486	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—RIPK2—Crohn's disease	5.17e-05	0.000486	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—IL2RA—Crohn's disease	5.17e-05	0.000486	CbGpPWpGaD
Octreotide—Dizziness—Prednisone—Crohn's disease	5.14e-05	0.000534	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—UBE2D1—Crohn's disease	5.11e-05	0.000481	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—IL2RA—Crohn's disease	5.08e-05	0.000478	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—IL3—Crohn's disease	5.04e-05	0.000474	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—SMAD3—Crohn's disease	5.03e-05	0.000474	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PTGER4—Crohn's disease	5.03e-05	0.000474	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—RIPK2—Crohn's disease	4.96e-05	0.000466	CbGpPWpGaD
Octreotide—Vomiting—Prednisone—Crohn's disease	4.95e-05	0.000514	CcSEcCtD
Octreotide—Rash—Prednisone—Crohn's disease	4.9e-05	0.000509	CcSEcCtD
Octreotide—Dermatitis—Prednisone—Crohn's disease	4.9e-05	0.000509	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—RASGRP1—Crohn's disease	4.88e-05	0.000459	CbGpPWpGaD
Octreotide—Headache—Prednisone—Crohn's disease	4.87e-05	0.000506	CcSEcCtD
Octreotide—SSTR4—Signaling by GPCR—CXCL8—Crohn's disease	4.84e-05	0.000455	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IL3—Crohn's disease	4.83e-05	0.000455	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—RBX1—Crohn's disease	4.77e-05	0.000449	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—IL2RA—Crohn's disease	4.69e-05	0.000441	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—RASGRP1—Crohn's disease	4.67e-05	0.00044	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—IL2RA—Crohn's disease	4.66e-05	0.000439	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PTGER4—Crohn's disease	4.64e-05	0.000437	CbGpPWpGaD
Octreotide—Nausea—Prednisone—Crohn's disease	4.62e-05	0.00048	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—UBE2D1—Crohn's disease	4.53e-05	0.000427	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—JAK2—Crohn's disease	4.42e-05	0.000416	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—SOCS1—Crohn's disease	4.42e-05	0.000416	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—RIPK2—Crohn's disease	4.4e-05	0.000414	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IL3—Crohn's disease	4.29e-05	0.000403	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—JAK2—Crohn's disease	4.24e-05	0.000399	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—SOCS1—Crohn's disease	4.24e-05	0.000399	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—TYK2—Crohn's disease	4.21e-05	0.000396	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—UBE2D1—Crohn's disease	4.18e-05	0.000394	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—RASGRP1—Crohn's disease	4.15e-05	0.00039	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—RIPK2—Crohn's disease	4.06e-05	0.000382	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—CXCL8—Crohn's disease	4.04e-05	0.00038	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—TYK2—Crohn's disease	4.04e-05	0.00038	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—JAK2—Crohn's disease	4.02e-05	0.000378	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IL3—Crohn's disease	3.96e-05	0.000372	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—CXCL8—Crohn's disease	3.87e-05	0.000364	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—JAK2—Crohn's disease	3.85e-05	0.000363	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—RASGRP1—Crohn's disease	3.83e-05	0.00036	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—SMAD3—Crohn's disease	3.81e-05	0.000359	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—JAK2—Crohn's disease	3.76e-05	0.000354	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—SOCS1—Crohn's disease	3.76e-05	0.000353	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—CXCL8—Crohn's disease	3.67e-05	0.000345	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—SMAD3—Crohn's disease	3.66e-05	0.000344	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—TYK2—Crohn's disease	3.58e-05	0.000337	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—IL2RA—Crohn's disease	3.53e-05	0.000332	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—CXCL8—Crohn's disease	3.52e-05	0.000331	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—JAK2—Crohn's disease	3.47e-05	0.000327	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—SOCS1—Crohn's disease	3.47e-05	0.000326	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—CXCL8—Crohn's disease	3.43e-05	0.000323	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—JAK2—Crohn's disease	3.42e-05	0.000322	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IL2RA—Crohn's disease	3.39e-05	0.000319	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—TYK2—Crohn's disease	3.31e-05	0.000311	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—TYK2—Crohn's disease	3.28e-05	0.000309	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—SMAD3—Crohn's disease	3.24e-05	0.000305	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—CXCL8—Crohn's disease	3.17e-05	0.000298	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—JAK2—Crohn's disease	3.15e-05	0.000297	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—JAK2—Crohn's disease	3.13e-05	0.000295	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—CXCL8—Crohn's disease	3.12e-05	0.000293	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IL2RA—Crohn's disease	3e-05	0.000283	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—SMAD3—Crohn's disease	2.99e-05	0.000282	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—CXCL8—Crohn's disease	2.88e-05	0.000271	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CXCL8—Crohn's disease	2.86e-05	0.000269	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IL2RA—Crohn's disease	2.77e-05	0.000261	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—IL6—Crohn's disease	2.72e-05	0.000256	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—TYK2—Crohn's disease	2.49e-05	0.000234	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—TYK2—Crohn's disease	2.39e-05	0.000224	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—JAK2—Crohn's disease	2.37e-05	0.000223	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—STAT3—Crohn's disease	2.3e-05	0.000216	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—JAK2—Crohn's disease	2.28e-05	0.000214	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CXCL8—Crohn's disease	2.17e-05	0.000204	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TYK2—Crohn's disease	2.12e-05	0.000199	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CXCL8—Crohn's disease	2.08e-05	0.000195	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—IL6—Crohn's disease	2.06e-05	0.000194	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—JAK2—Crohn's disease	2.02e-05	0.00019	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—IL6—Crohn's disease	1.98e-05	0.000186	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TYK2—Crohn's disease	1.95e-05	0.000184	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—JAK2—Crohn's disease	1.86e-05	0.000175	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CXCL8—Crohn's disease	1.84e-05	0.000173	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—IL6—Crohn's disease	1.75e-05	0.000165	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—STAT3—Crohn's disease	1.74e-05	0.000164	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CXCL8—Crohn's disease	1.7e-05	0.00016	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—STAT3—Crohn's disease	1.67e-05	0.000157	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—IL6—Crohn's disease	1.62e-05	0.000152	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—IL6—Crohn's disease	1.61e-05	0.000151	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—STAT3—Crohn's disease	1.48e-05	0.000139	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—STAT3—Crohn's disease	1.37e-05	0.000129	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—IL6—Crohn's disease	1.22e-05	0.000115	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IL6—Crohn's disease	1.17e-05	0.00011	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IL6—Crohn's disease	1.03e-05	9.74e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IL6—Crohn's disease	9.55e-06	8.99e-05	CbGpPWpGaD
